Nily Daudi

  • Citations Per Year
Learn More
BACKGROUND/AIMS Lamivudine is a potent inhibitor of hepatitis B virus (HBV) replication. This prospective open study reports the results of lamivudine treatment in children with chronic hepatitis B infection who did not respond to previous interferon treatment. PATIENTS AND METHODS Lamivudine, 3 mg/kg/day (maximum, 100 mg/day), was given for 52 weeks to(More)
  • 1